The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: Current situation;El problema creciente de la resistencia antibiótica en bacilos gramnegativos: situación actual

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 2, 2010, Pages 25-31

  Martínez Martínez, Luis ^a   Calvo, Jorge ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

lactamases; Acinetobacter baumannii; Carbapenems; Enterobacteria; Multiresistance; Pseudomonas aeruginosa

Indexed keywords

ACYLTRANSFERASE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEPHAMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; POLYMYXIN; PORIN; QUINOLONE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; ENTEROBACTERIACEAE; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; MULTICENTER STUDY; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SPAIN; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER BAUMANNII; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; LACTAMS; PORINS; R FACTORS; SPAIN; STENOTROPHOMONAS MALTOPHILIA; SUBSTRATE SPECIFICITY; WORLD HEALTH;

EID: 79551539385     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(10)70027-6     Document Type: Article

References (49)

1. R. Bonnet β-lactamines et enterobacteries P. Courvalin, R. Leclercq, E. Bingen, Antibiogramme 2006 ESKA Paris 141 162
2. E.C. Nelson, and B.G. Elisha Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli Antimicrob Agents Chemother 43 1999 957 959
3. D.M. Tracz, D.A. Boyd, R. Hizon, E. Bryce, A. McGeer, and M. Ofner-Agostini Canadian Nosocomial Infection Surveillance Program. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates FEMS Microbiol Lett 270 2007 265 271
4. F. Fernández-Cuenca, L. Martínez-Martínez, G. Amblar, D.J. Biedenbach, R.N. Jones, and A. Pascual Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin Clin Microbiol Infect 12 2006 197 198 (Pubitemid 43379354)
5. N.D. Hanson, and C.C. Sanders Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae Curr Pharm Des 5 1999 881 894
6. J.W. Chow, M.J. Fine, D.M. Shlaes, J.P. Quinn, D.C. Hooper, and M.P. Johnson Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 1991 585 590
7. W.L. Yu, W.C. Ko, K.C. Cheng, H.E. Chen, C.C. Lee, and Y.C. Chuang Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan Diagn Microbiol Infect Dis 61 2008 460 467
8. D.L. Paterson, and R.A. Bonomo Extended-Spectrum β-Lactamases: a clinical update Clin Microbiol Rev 18 2005 657 686
9. L. Martínez-Martínez, S. Hernández-Alles, S. Alberti, J.M. Tomás, V.J. Benedi, and G.A. Jacoby In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins Antimicrob Agents Chemother 40 1996 342 348
10. L. Poirel, C. Heritier, I. Podglajen, W. Sougakoff, L. Gutmann, and P. Nordmann Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem Antimicrob Agents Chemother 47 2003 755 758
11. L. Martínez-Martínez, A. Pascual, S. Hernández- Alles, D. Álvarez-Díaz, A.I. Suárez, and J. Tran Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae Antimicrob Agents Chemother 43 1999 1669 1673
12. J. Oteo, A. Delgado-Iribarren, D. Vega, V. Bautista, M.C. Rodríguez, and M. Velasco Emergence of imipenem resistance in clinical Escherichia coli during therapy Int J Antimicrob Agents 32 2008 534 537
13. A. Mena, V. Plasencia, L. García, O. Hidalgo, J.I. Ayestarán, and S. Alberti Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development J Clin Microbiol 44 2006 2831 2837
14. J. Rodríguez-Baño, M.D. Navarro, L. Romero, L. Martínez-Martínez, M.A. Muniain, and E.J. Perea Epidemiology and clinical features of infections caused by extendedspectrum beta-lactamase- producing Escherichia coli in nonhospitalized patients J Clin Microbiol 42 2004 1089 1094
15. J.R. Hernández, A. Pascual, R. Cantón, and L. Martínez-Martínez Grupo de Estudio de Infeccion Hospitalaria (GEIH). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002) Enferm Infecc Microbiol Clin 21 2003 77 82
16. J.R. Hernández, L. Martínez-Martínez, R. Cantón, T.M. Coque, and A. Pascual Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain Antimicrob Agents Chemother 49 2005 2122 2125
17. M.A. Díaz, J.R. Hernández, L. Martínez- Martínez, J. Rodríguez-Baño, and A. Pascual Grupo de Estudio de Infección Hospitalaria (GEIH). Escherichia coli y Klebsiella pneumoniae productoras de beta-lactamasas de espectro extendido en hospitales españoles: segundo estudio multicéntrico (proyecto GEIH-BLEE 2006) Enferm Infecc Microbiol Clin 27 2009 496 502
18. K. Diestra, T.M. Coque, E. Miró, J. Oteo, C.J. Nicolau, and J. Campos Red Española de Investigación en Patología Infecciosa. Caracterización y epidemiología molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales españoles (2004) Enferm Infecc Microbiol Clin 26 2008 404 410
19. J. Oteo, K. Diestra, C. Juan, V. Bautista, A. Novais, and M. Pérez-Vázquez Spanish Network in Infectious Pathology Project (REIPI). Extended-spectrum beta-lactamase producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2 Int J Antimicrob Agents 34 2009 173 176
20. A. Reyes, H. Bello, M. Domínguez, S. Mella, R. Zemelman, and G. González Prevalence and types of class 1 integrons in aminoglycoside-resistant Enterobacteriaceae from several Chilean hospitals J Antimicrob Chemother 51 2003 317 321
21. L. Martínez-Martínez, A. Pascual, M.C. Conejo, I. García, P. Joyanes, and A. Domenech-Sánchez Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production Antimicrob Agents Chemother 46 2002 3926 3932
22. J. Rodríguez-Baño, and A. Pascual Clinical significance of extended-spectrum beta-lactamases Expert Rev Anti Infect Ther 6 2008 671 683
23. G.A. Jacoby AmpC beta-lactamases Clin Microbiol Rev 22 2009 161 182
24. F.J. Pérez-Pérez, and N.D. Hanson Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR J Clin Microbiol 40 2002 2153 2162
25. C. Mata, E. Miró, A. Rivera, B. Mirelis, P. Coll, and F. Navarro Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007 Clin Microbiol Infect 2009 Jun 11. [Epub ahead of print]
26. M. Tato, T.M. Coque, P. Ruiz-Garbajosa, V. Pintado, J. Cobo, and H.S. Sader Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis 45 2007 1171 1178
27. P. Nordmann, and L. Poirel Emerging carbapenemses in Gram-negative aerobes Clin Microbiol Infect 8 2002 321 331
28. L. Martínez-Martínez, A. Pascual, and G.A. Jacoby Quinolone resistance from a transferable plasmid Lancet 351 1998 797 799
29. L. Martínez-Martínez, A. Pascual, I. García, J. Tran, and G.A. Jacoby Interaction of plasmid and host quinolone resistance J Antimicrob Chemother 51 2003 1037 1039
30. J.M. Rodríguez-Martínez, C. Pichardo, I. García, M.E. Pachón-Ibáñez, F. Docobo-Pérez, and A. Pascual Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1 Clin Microbiol Infect 14 2008 691 697
31. L. Martínez-Martínez, M.E. Cano, J.M. Rodríguez- Martínez, J. Calvo, and A. Pascual Plasmid-mediated quinolone resistance Expert Rev Anti Infect Ther 6 2008 685 711
32. M.E. Cano, J.M. Rodríguez-Martínez, J. Agüero, A. Pascual, J. Calvo, and J.M. García-Lobo Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain J Clin Microbiol 47 2009 2033 2039
33. S. Lavilla, J.J. González-López, M. Sabaté, A. García-Fernández, M.N. Larrosa, and R.M. Bartolomé Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain J Antimicrob Chemother 61 2008 291 295
34. M.E. Cano, J. Calvo, J. Agüero, J.M. Rodríguez- Martínez, A. Pascual, and L. Martínez-Martínez Plasmid-mediated quinolone resistance among enterobacteria with reduced susceptibility or resistant to ciprofloxacin but susceptible to nalidixic acid 2007 47th Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL Sept 17-20. Abstract C2-152
35. N. Mesaros, P. Nordmann, P. Plésiat, M. Roussel-Delvallez, J. Van Eldere, and Y. Glupczynski Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium Clin Microbiol Infect 13 2007 560 578 (Pubitemid 46730662)
36. J.M. Rodríguez-Martínez, L. Poirel, and P. Nordmann Extended-spectrum cephalosporinases in Pseudomonas aeruginosa Antimicrob Agents Chemother 53 2009 1766 1771
37. E. Bouza, F. García-Garrote, E. Cercenado, M. Marín, M.S. Díaz, and I. Sánchez Romero Grupo Español para el estudio de Pseudomonas aeruginosa: Pseudomonas aeruginosa: a multicenter study in 136 hospitals in Spain Rev Esp Quimioter 16 2003 41 52
38. O. Gutiérrez, C. Juan, E. Cercenado, F. Navarro, E. Bouza, and P. Coll Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals Antimicrob Agents Chemother 51 2007 4329 4335
39. D.M. Livermore Of Pseudomonas, porins, pumps and carbapenems J Antimicrob Chemother 47 2001 247 250
40. A. Oliver Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future Enferm Infecc Microbiol Clin 27 2009 255 256
41. D. Landman, C. Georgescu, D.A. Martin, and J. Quale Polymyxins revisited Clin Microbiol Rev 21 2008 449 465
42. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
43. F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Vila, G. Bou, and J.M. Cisneros Grupo de Estudio de Infección Hospitalaria (GEIH). Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) Enferm Infecc Microbiol Clin 22 2004 267 271
44. C. Fernández-Mazarrasa, O. Mazarrasa, J. Calvo, A. Del Arco, and L. Martínez-Martínez High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest J Clin Microbiol 47 2009 827 829
45. A. Ribera, J. Vila, F. Fernández-Cuenca, L. Martínez- Martínez, A. Pascual, and A. Beceiro Spanish Group for Nosocomial Infection (GEIH). Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals Antimicrob Agents Chemother 48 2004 364 365
46. F. Fernández-Cuenca, L. Martínez-Martínez, M.C. Conejo, J.A. Ayala, E.J. Perea, and A. Pascual Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii J Antimicrob Chemother 51 2003 565 574
47. J.M. Cisneros, J. Rodríguez-Baño, F. Fernández- Cuenca, A. Ribera, J. Vila, and A. Pascual Spanish Group for Nosocomial Infection (GEIH). Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study Clin Microbiol Infect 11 2005 874 879
48. M. Denton, and K.G. Kerr Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin Microbiol Rev 11 1998 57 80
49. C.H. Lai, C.Y. Chi, H.P. Chen, T.L. Chen, C.J. Lai, and C.P. Fung Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia J Microbiol Immunol Infect 37 2004 350 358